Apex Capital’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Apex Capital’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$8.61M	Sell	382,000 -18,000	-5%	-$369K	0.92%	34
2015 Q3	$6.64M	Buy	400,000 +11,900	+3%	+$239K	0.63%	45
2015 Q2	$8.73M	Buy	388,100 +63,100	+19%	+$1.56M	0.76%	42
2015 Q1	$8.38M	Sell	325,000 -20,100	-6%	-$510K	0.6%	51
2014 Q4	$7.51M	Buy	+345,100	New	+$7.07M	0.53%	49

Other funds holding OMED

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Apex Capital's OMED Position: Q4 2015 in Review

Apex Capital reduced its OncoMed Pharmaceuticals, Inc. (OMED) stake by 4.5% in Q4 2015, selling an estimated $369K and leaving 382,000 shares worth $8.61M. The position accounts for 0.92% of the portfolio, ranked #34.

Apex Capital first reported a position in OMED in Q4 2014 and has held it in 5 quarters since. The position peaked at $8.73M in Q2 2015. 83 funds tracked by Wall St. Rank hold OMED as of Q4 2015.

Apex Capital held 382,000 shares of OncoMed Pharmaceuticals, Inc. worth $8.61M as of Q4 2015.
Apex Capital sold 18,000 OncoMed Pharmaceuticals, Inc. shares in Q4 2015, an estimated $369K.
OncoMed Pharmaceuticals, Inc. made up 0.92% of Apex Capital's portfolio in Q4 2015, its #34 holding.
Apex Capital first reported a position in OncoMed Pharmaceuticals, Inc. in Q4 2014 and has held it in 5 quarters since.
Apex Capital's OncoMed Pharmaceuticals, Inc. position peaked at $8.73M in Q2 2015.
83 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q4 2015.

Based on Apex Capital's 13F filing for Q4 2015, filed 16 Feb 2016.